STOCK TITAN

[Form 4] Verastem, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Verastem, Inc. (VSTM): Director insider sale filed on Form 4. On 10/09/2025, the reporting person, a director, sold 8,333 shares of common stock in open-market transactions at a weighted average price of $9.06 per share under a Rule 10b5-1 trading plan. The trades occurred across prices ranging from $8.70 to $9.33. Following the transaction, the reporting person directly owned 8,333 shares.

Verastem, Inc. (VSTM): vendita interna da parte di un amministratore registrata sul Modulo 4. Il 10/09/2025, la persona che segnala, un amministratore, ha venduto 8.333 azioni ordinarie in operazioni di mercato aperto ad un prezzo medio ponderato di 9,06 USD per azione secondo un piano di negoziazione Rule 10b5-1. Le operazioni si sono svolte a prezzi compresi tra 8,70 e 9,33 USD. A seguito della transazione, la persona che segnala possedeva direttamente 8.333 azioni.

Verastem, Inc. (VSTM): venta por parte de directivo registrada en Formulario 4. El 10/09/2025, la persona informante, un director, vendió 8.333 acciones ordinarias en transacciones en el mercado abierto a un precio medio ponderado de 9,06 USD por acción, bajo un plan de negociación Rule 10b5-1. Las operaciones se llevaron a cabo a precios que oscilaron entre 8,70 y 9,33 USD. Tras la transacción, la persona informante poseía directamente 8.333 acciones.

Verastem, Inc. (VSTM): 이사 내부자 매도가 Form 4에 보고되었습니다. 2025년 10월 9일, 보고자이자 이사는 일반주식 8,333주를 공매도 거래로 매도했으며, 1주당 가중평균가 9.06 USD의 가격으로 Rule 10b5-1 거래 계획에 따라 실행되었습니다. 거래는 8.70 USD에서 9.33 USD 사이의 가격으로 이루어졌습니다. 거래 후 보고자는 직접 8,333주를 소유하고 있었습니다.

Verastem, Inc. (VSTM) : vente d'initié par un administrateur déposée sur le formulaire 4. Le 9/10/2025, la personne déclarant, un administrateur, a vendu 8 333 actions ordinaires lors d'opérations sur le marché ouvert à un cours moyen pondéré de 9,06 $ par action dans le cadre d'un plan de négociation Rule 10b5-1. Les transactions ont eu lieu à des prix allant de 8,70 à 9,33 $. À la suite de la transaction, la personne déclarant possédait directement 8 333 actions.

Verastem, Inc. (VSTM): Insider-Verkauf durch Directorsformular 4 gemeldet. Am 10.09.2025 verkaufte die meldende Person, ein Direktor, 8.333 Stammaktien in Open-Market-Transaktionen zu einem gewichteten Durchschnittspreis von 9,06 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans. Die Transaktionen fanden zu Preisen von 8,70 bis 9,33 USD statt. Nach der Transaktion besaß die meldende Person direkt 8.333 Aktien.

فيراستيم، إنك (VSTM): بيع داخلي من قبل مدير مُسجَّل في النموذج 4. في 9/10/2025، بايَع الشخص المبلّغ عنه، وهو مدير، 8,333 سهماً من الأسهم العادية في معاملات السوق المفتوح بسعر متوسط مرجّح قدره 9.06 دولاراً للسهم وفقاً لخطة تداول Rule 10b5-1. جرت التداولات بأسعار تتراوح بين 8.70 و9.33 دولاراً. عقب الصفقة، امتلك الشخص المبلّغ عنه 8,333 سهماً بشكل مباشر.

Verastem, Inc. (VSTM): 董事内幕交易已在表格4上披露。 2025年10月9日,信息披露人(董事)在公开市场交易中以加权平均价9.06美元/股出售了8,333股普通股,依据Rule 10b5-1交易计划执行。交易价格在8.70美元至9.33美元之间波动。交易完成后,该信息披露人直接持有8,333股。

Positive
  • None.
Negative
  • None.

Verastem, Inc. (VSTM): vendita interna da parte di un amministratore registrata sul Modulo 4. Il 10/09/2025, la persona che segnala, un amministratore, ha venduto 8.333 azioni ordinarie in operazioni di mercato aperto ad un prezzo medio ponderato di 9,06 USD per azione secondo un piano di negoziazione Rule 10b5-1. Le operazioni si sono svolte a prezzi compresi tra 8,70 e 9,33 USD. A seguito della transazione, la persona che segnala possedeva direttamente 8.333 azioni.

Verastem, Inc. (VSTM): venta por parte de directivo registrada en Formulario 4. El 10/09/2025, la persona informante, un director, vendió 8.333 acciones ordinarias en transacciones en el mercado abierto a un precio medio ponderado de 9,06 USD por acción, bajo un plan de negociación Rule 10b5-1. Las operaciones se llevaron a cabo a precios que oscilaron entre 8,70 y 9,33 USD. Tras la transacción, la persona informante poseía directamente 8.333 acciones.

Verastem, Inc. (VSTM): 이사 내부자 매도가 Form 4에 보고되었습니다. 2025년 10월 9일, 보고자이자 이사는 일반주식 8,333주를 공매도 거래로 매도했으며, 1주당 가중평균가 9.06 USD의 가격으로 Rule 10b5-1 거래 계획에 따라 실행되었습니다. 거래는 8.70 USD에서 9.33 USD 사이의 가격으로 이루어졌습니다. 거래 후 보고자는 직접 8,333주를 소유하고 있었습니다.

Verastem, Inc. (VSTM) : vente d'initié par un administrateur déposée sur le formulaire 4. Le 9/10/2025, la personne déclarant, un administrateur, a vendu 8 333 actions ordinaires lors d'opérations sur le marché ouvert à un cours moyen pondéré de 9,06 $ par action dans le cadre d'un plan de négociation Rule 10b5-1. Les transactions ont eu lieu à des prix allant de 8,70 à 9,33 $. À la suite de la transaction, la personne déclarant possédait directement 8 333 actions.

Verastem, Inc. (VSTM): Insider-Verkauf durch Directorsformular 4 gemeldet. Am 10.09.2025 verkaufte die meldende Person, ein Direktor, 8.333 Stammaktien in Open-Market-Transaktionen zu einem gewichteten Durchschnittspreis von 9,06 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans. Die Transaktionen fanden zu Preisen von 8,70 bis 9,33 USD statt. Nach der Transaktion besaß die meldende Person direkt 8.333 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bunn Paul A.

(Last) (First) (Middle)
C/O VERASTEM, INC.,
117 KENDRICK ST., SUITE 500

(Street)
NEEDHAM MA 02494

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Verastem, Inc. [ VSTM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/09/2025 S(1) 8,333(1) D $9.06(2) 8,333 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.70 through $9.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
/s/ Daniel Calkins, Attorney in Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Verastem (VSTM) report?

A director sold 8,333 shares of common stock on 10/09/2025.

What was the sale price in the Verastem (VSTM) Form 4?

The weighted average sale price was $9.06 per share, with trades between $8.70 and $9.33.

Was the Verastem (VSTM) sale under a trading plan?

Yes, it was effected under a Rule 10b5-1 trading plan.

How many shares does the insider hold after the sale?

The reporting person directly owned 8,333 shares after the transaction.

What is the insider’s relationship to Verastem (VSTM)?

The reporting person is a Director of Verastem, Inc.

What form reported the Verastem (VSTM) insider trade?

It was disclosed on Form 4.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

585.30M
58.28M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM